|
New Delhi, Jan 02: The subject expert committee on Saturday recommended Bharat Biotech’s Covaxin too for restricted emergency use in India.
Representational Image
“Grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains, to M/s Bharat Biotech International Ltd., Hyderabad,” statement by Union Health Ministry reads.
This came a day after the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO), India’s drug regulator, recommended conditional use of the vaccine.
This is the second Covid-19 vaccine which has been recommended for…
